1. Humalog Mix50 100 i.e./ml Pen suspenzija za injiciranje

Humalog Mix50 100 i.e./ml Pen suspenzija za injiciranje

Insulin lispro

General information

Drug nameHumalog Mix50 100 i.e./ml Pen suspenzija za injiciranje
Medicine nameInsulin lispro
National drug code3000024
PMS ID—
SNOMED descriptive name code—
Legal statusZdravilo z dovoljenjem za promet
Drug groupBiological Medicinal Product
OriginatorYes
Orphan drugNo

Marketing authorization

Procedure typePrenehanje veljavnosti dovoljenja za promet
No. and date of decision/certificateEU/1/96/007/017, 30. 9. 2014
Authorization validity date30. 9. 2014
Marketing end date30. 3. 2016
Application type—
Authorization/certificate holderEli Lilly Nederland BV

Drug safety monitoring

Additional safety monitoringNo
Precautionary measure/dispensing restrictions—
Pregnancy prevention programmeNo
Controlled access programme(s)No

ATC codes

AALIMENTARY TRACT AND METABOLISM
A10DRUGS USED IN DIABETES
A10AInsulins and analogues
A10ADInsulins and analogues for injection, intermediate- or long-acting combined with fast-acting
A10AD04insulin lispro

Route of administration

Route of administration name
Subkutana uporaba

Settlement data for compulsory health insurance billing

Substitute medicine

Preparation—
Valid from – to—

Clinical use data

Methods of use—
Indications—
Rounding factor—
DivisibleNo
Division for easier swallowingNo
Division for dosage adjustmentNo
Paediatric populationNo

Shortage actions

Substitute medicine in case of shortage - industrial medicine—
Substitute medicine in case of shortage - magistral or galenic medicine—
Prescribing restriction in case of drug shortageNo
Dispensing restriction in case of shortage or emergencyNo
Dispensing restriction for foreign prescriptions in case of shortage or emergencyNo
Export restrictionNo

Drug status

Announced permanent cessation of marketing of the medicinal product.

Last drug update date:9. 7. 2026
TEST APPLICATION